Assessment and management of a young person with a severe disability is multifaceted and complex. Variations of puberty can cause major concerns for parents and carers, with fears of imminent menstruation, peer and personal differences, concern for height outcome, as well as grief for a loss of childhood. Addressing physical, emotional, and social issues assists in optimizing outcomes. This article outlines specific evaluation and detailed management strategies for female and male pubertal problems in the context of disability, including treatments for extreme pubertal delay or acceleration, menstrual management at different ages, contraceptive issues, and sexual function and choices for both sexes.
Worley G., Houlihan CM, Herman-Giddens ME, et al. Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey. Paediatrics. 2002;110:897-902.
2.
Zacharin M.Current advances in bone health of disabled children. Curr Opin Pediatr. 2004;16:545-555.
3.
Saggese G., Baroncelli GI, Bertelloni S.Puberty and bone development. Best Pract Res Clin Endocrinol Metab. 2002;1:53-64.
4.
Mora S., Gilsanz V.Establishment of peak bone mass. Endocrinol Metab Clin North Am. 2003;32:39-63.
5.
Schoenau E., Neu CM, Rauch F., Manz F.Gender specific pubertal changes in volumetric cortical bone mineral density at the proximal radius. Bone. 2002;31:110-113.
6.
Gunther DS, Diekma DSAttenuating growth in children with profound disability. Arch Paediatr Adolesc Med. 2006;160:1013-1017.
7.
Ashley's blog. http://ashleytreatment.spaces.live.com/blog . Accessed September 8, 2008.
8.
Albanese A., Hopper NWSuppression of menstruation in adolescents with severe learning disabilities . Arch Dis Child. 2007;92:629-632.
9.
Seeger JD, Loughlin J., Eng PM, Clifford CR, Cutone J., Walker AMRisk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. Obstet Gynecol. 2007;110:587-593.
10.
Jick S., Kaye JA, Li L., Jick H.Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35microg of ethinyl estradiol. Contraception. 2007;76:4-7.
11.
O'Brien MD, Guillebaud J.Contraception for women with epilepsy. Epilepsia. 2006;47:1419-1422.
12.
Lara-Torre E., Edwards CP, Perlman S., et al. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Paediatr Adolesc Gynecol. 2004; 17:17-21.
